Clinical Trial Update: Podocyte Retinoids [Phase 2]

View source ↗

Summary

Phase 2 trial update for podocyte retinoids sponsored by NIDDK; completed with results posted in 2017 for glomerular diseases including collapsing glomerulopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Collapsing Glomerulopathy
• Glomerulosclerosis Focal Segmental

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Collapsing Glomerulopathy, Glomerulosclerosis, Focal Segmental | Phase 2 | Status: COMPLETED | Results posted: 2017-12-13